Vestagen Technical Textiles announces its inaugural participation in the 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) this week, hosted by The American Society for Microbiology. Vestagen will exhibit its fluid repellant Vestex performance medical apparel at the conference, which will also be the subject of a poster session with Dr. Ruta Dubinskaite.
Vestex uses exclusively licensed and patented technology to repel blood and bodily fluids, wick away perspiration and contains an antimicrobial to control odors. The innovative, nanotechnology-based uniforms keep healthcare workers clean, cool and dry.
Earlier this year, a research team led by Dr. Ruta Dubinskaite, Margaret Cotton, Dr. Christopher Gibson, Dr. Thomas Walsh, Dr. Shmuel Shoham and Dr. Matthew Hardwick tested Vestex in emergency rooms and critical care departments where splashes and splatters of bodily fluids are daily occurrences. To evaluate the impact of Vestex fabric treatment on healthcare worker clothing, doctors tested shirts with one half control fabric and one half Vestex fabric.
Twenty-nine shirts were autoclaved and given to health care workers in the emergency and critical care departments at Washington Hospital Center. Workers wore the scrub shirts for one eight- to 12-hour shift. Shirt microbial contamination was assessed at baseline and at the end of the shift by swabbing 12 distinct areas of the garments for culture. Total colony counts of cultures from each shirt compared the Vestex treated portion to the untreated portion. Overall, the Vestex-treated portion of the scrub shirts had fewer pathogens at the end of the shift than the control fabric. Researchers concluded that there is, a strong trend suggesting that Vestex treated garments are more effective at reducing microbial burden than control fabric.
The results are encouraging and add to the clinical and laboratory evidence base for Vestex, says Ben Favret, president and CEO of Vestagen.Â
Engineered as a first line of defense against blood and other bodily fluids, Vestex comes at a time when the nations healthcare industry is on high alert. Mounting data suggests that microbial contamination can occur via the physical transfer of microorganisms from textiles such as scrubs, lab coats and bed linens.
Its well documented in the medical literature that fluid barriers protect workers in a clinical setting, but most of them are hot and uncomfortable to wear, Favret adds. Vestex is a breathable, comfortable solution, yet maintains the barrier protection workers need to stay safe.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.